TCMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
TACTILE SYSTEMS TECHNOLOGY INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$22.73+0.21 (+0.93%)
Close on Oct 19, 2026
- Market cap
- $524.13M
- P/E (TTM)
- 21.0
- Dividend yield
- –
TACTILE SYSTEMS TECHNOLOGY INC revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales revenue | $292.59M | $256.01M | $239.49M | $211.35M | $177.91M | $161.50M | $162.90M | $128.79M | $97.64M | – | 88.8% | +14.3% |
| Lymphedema products | $278.38M | $259.36M | $241.72M | $212.27M | $202.91M | – | – | – | – | – | 84.5% | +7.3% |
| Airway clearance products | $51.14M | $33.62M | $32.70M | $34.52M | $5.14M | – | – | – | – | – | 15.5% | +52.1% |
| Rental revenue | $36.93M | $36.97M | $34.93M | $35.44M | $30.14M | $25.63M | $26.59M | $14.97M | $11.64M | $7.90M | 11.2% | -0.1% |
| Entre/Actitouch systems | – | – | – | – | – | – | $18.17M | $11.82M | $8.94M | $11.13M | – | – |
| Flexitouch system | – | – | – | $212.27M | $202.91M | $187.13M | $171.32M | $131.94M | $100.34M | $73.41M | – | – |
| Other products | – | – | – | – | – | $23.22M | $18.17M | $11.82M | – | – | – | – |
| Entre system | – | – | – | – | $26.69M | $23.22M | $18.17M | – | – | – | – | – |
| AffloVest | – | – | – | $34.52M | $5.14M | – | – | – | – | – | – | – |
By region
From the segment and revenue-disaggregation notes of Tactile Systems Technology's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.